Prothena Corporation plc

US$7.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PRTAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (16.37%)
Div yield —
ROE (8.50%)
Biotechnology
Beta (5Y) (0.21)
PE TTM —
TSR TTM (25.86%)
Mkt cap US$409.3M
ROIC (8.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$10
28.50%
413.39%
Hold 7|1|4|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.16
0.16
11.53%
24.86%
33.82%
29.37%
Revenue$M
21.75
22.24
21.79
22.54
6.48%
7.16%
2.54%
8.96%
Peers (US$409.3M)
Cap (US$)
PE
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
0.654
(0.423)
(0.323)
EBIT/Intx
0.937
0.185
0.232
Own earn%
(217.21)
96.08
83.49
Sh yield%
16.02
24.90
24.99
Owners
Insiders/Inst%
1.49
69.92
Short interest%
1.86
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
1–9
$1 testx
0.6
Incr. ROIC%
4